| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
4,061 |
3,019 |
$112K |
| 99214 |
Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity |
2,603 |
2,112 |
$67K |
| 96372 |
Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular |
1,540 |
1,271 |
$12K |
| 3008F |
|
1,520 |
1,149 |
$2K |
| 85025 |
Blood count; complete (CBC), automated, and automated differential WBC count |
620 |
497 |
$2K |
| J1030 |
Injection, methylprednisolone acetate, 40 mg |
569 |
489 |
$2K |
| 1160F |
|
1,469 |
1,123 |
$1K |
| 1159F |
|
1,463 |
1,116 |
$1K |
| 87804 |
Infectious agent antigen detection by immunoassay; Influenza, each type |
201 |
93 |
$1K |
| 3074F |
|
980 |
746 |
$1K |
| 3078F |
|
898 |
664 |
$982.40 |
| 99212 |
Office or other outpatient visit for the evaluation and management of an established patient, straightforward |
45 |
40 |
$904.99 |
| 1125F |
|
1,189 |
897 |
$840.00 |
| 36415 |
Collection of venous blood by venipuncture |
1,206 |
994 |
$804.60 |
| 90674 |
|
67 |
53 |
$513.56 |
| 3079F |
|
303 |
250 |
$450.00 |
| 90471 |
Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine |
59 |
44 |
$335.40 |
| 3077F |
|
198 |
144 |
$330.00 |
| 82948 |
|
381 |
292 |
$317.50 |
| 81001 |
|
274 |
221 |
$304.61 |
| 96110 |
Developmental screening, with scoring and documentation, per standardized instrument |
35 |
29 |
$294.53 |
| 87880 |
Infectious agent antigen detection by immunoassay; Streptococcus, group A |
48 |
40 |
$279.64 |
| 87426 |
Infectious agent antigen detection, SARS-CoV-2 (COVID-19) |
15 |
15 |
$262.15 |
| 92551 |
|
35 |
29 |
$229.24 |
| J3420 |
Injection, vitamin b-12 cyanocobalamin, up to 1000 mcg |
231 |
188 |
$213.91 |
| 90688 |
|
29 |
27 |
$200.91 |
| 3075F |
|
72 |
54 |
$170.00 |
| 1126F |
|
132 |
106 |
$150.00 |
| 81025 |
|
55 |
37 |
$136.94 |
| 3080F |
|
53 |
42 |
$130.00 |
| 99173 |
|
54 |
44 |
$95.38 |
| J1885 |
Injection, ketorolac tromethamine, per 15 mg |
91 |
79 |
$88.21 |
| J1020 |
Injection, methylprednisolone acetate, 20 mg |
25 |
24 |
$63.20 |
| 80305 |
|
16 |
13 |
$57.64 |
| 83036 |
Hemoglobin; glycosylated (A1C) |
135 |
110 |
$33.09 |
| J0696 |
Injection, ceftriaxone sodium, per 250 mg |
34 |
34 |
$24.58 |
| G0008 |
Administration of influenza virus vaccine |
12 |
12 |
$15.42 |
| G8754 |
Most recent diastolic blood pressure < 90 mmhg |
1,247 |
923 |
$0.00 |
| G8755 |
Most recent diastolic blood pressure >= 90 mmhg |
14 |
12 |
$0.00 |
| G9664 |
Patients who are currently statin therapy users or received an order (prescription) for statin therapy |
140 |
101 |
$0.00 |
| G8420 |
Bmi is documented within normal parameters and no follow-up plan is required |
42 |
31 |
$0.00 |
| 80502 |
|
16 |
14 |
$0.00 |
| G8753 |
Most recent systolic blood pressure >= 140 mmhg |
147 |
108 |
$0.00 |
| G8730 |
Pain assessment documented as positive using a standardized tool and a follow-up plan is documented |
397 |
303 |
$0.00 |
| G8417 |
Bmi is documented above normal parameters and a follow-up plan is documented |
432 |
334 |
$0.00 |
| G8752 |
Most recent systolic blood pressure < 140 mmhg |
1,171 |
874 |
$0.00 |
| G8506 |
Patient receiving angiotensin converting enzyme (ace) inhibitor or angiotensin receptor blocker (arb) therapy |
17 |
12 |
$0.00 |
| G8427 |
Eligible clinician attests to documenting in the medical record they obtained, updated, or reviewed the patient's current medications |
589 |
455 |
$0.00 |
| G8731 |
Pain assessment using a standardized tool is documented as negative, no follow-up plan required |
94 |
75 |
$0.00 |